ARTICLE | Clinical News
Catalyst Pharma preclinical data
June 27, 2011 7:00 AM UTC
In a rat model of infantile spasms, CPP-115 significantly reduced observed infantile spasms for 3 times longer than vigabatrin (p<0.05). The GABA transaminase inhibitor has Orphan Drug designation in the U.S. for the indication. The company plans to submit an IND for the product next quarter. ...